Clark Kenneth A
SEC insider (Form 3/4/5 filer). CIK 0001561736. Director at Summit Therapeutics Inc. (SMMT). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in MIAMI, FL.
Companies Clark Kenneth A has filed insider reports for
- Summit Therapeutics Inc. (SMMT): Director
Clark Kenneth A
CIK: 0001561736
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Summit Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 2, 2026SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
35K shares- - Jan 2, 2026SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
17.8K shares at avg. $8.76- - Jan 2, 2025SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
35K shares- - Jan 2, 2025SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
17K shares at avg. $9.18- - Oct 11, 2024SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 17,796 | $8.76 | - | Direct |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 16,991 | $9.18 | - | Direct |
| Oct 11, 2024 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 200,000 | - | - | Direct |
1-5 of 5 transactions